BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 26616206)

  • 1. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation.
    Robotham JV; Graves N; Cookson BD; Barnett AG; Wilson JA; Edgeworth JD; Batra R; Cuthbertson BH; Cooper BS
    BMJ; 2011 Oct; 343():d5694. PubMed ID: 21980062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting.
    Kang J; Mandsager P; Biddle AK; Weber DJ
    Infect Control Hosp Epidemiol; 2012 May; 33(5):477-86. PubMed ID: 22476274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of universal MRSA screening on admission to surgery.
    Murthy A; De Angelis G; Pittet D; Schrenzel J; Uckay I; Harbarth S
    Clin Microbiol Infect; 2010 Dec; 16(12):1747-53. PubMed ID: 20331684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
    Collins J; Raza M; Ford M; Hall L; Brydon S; Gould FK
    J Hosp Infect; 2011 Jun; 78(2):81-5. PubMed ID: 21507518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methicillin-resistant Staphylococcus aureus prevention strategies in the ICU: a clinical decision analysis*.
    Ziakas PD; Zacharioudakis IM; Zervou FN; Mylonakis E
    Crit Care Med; 2015 Feb; 43(2):382-93. PubMed ID: 25377019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore.
    Win MK; Soliman TA; Lee LK; Wong CS; Chow A; Ang B; Roman CL; Leo YS
    BMC Infect Dis; 2015 Sep; 15():391. PubMed ID: 26419926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project.
    Reilly JS; Stewart S; Christie P; Allardice G; Smith A; Masterton R; Gould IM; Williams C
    J Hosp Infect; 2010 Jan; 74(1):35-41. PubMed ID: 19959256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.
    Brown J; Paladino JA
    Pharmacoeconomics; 2010; 28(7):567-75. PubMed ID: 20550222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal screening for meticillin-resistant Staphylococcus aureus in acute care: risk factors and outcome from a multicentre study.
    Reilly JS; Stewart S; Christie P; Allardice GM; Stari T; Matheson A; Masterton R; Gould IM; Williams C
    J Hosp Infect; 2012 Jan; 80(1):31-5. PubMed ID: 22104473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of supplementing a broth-enriched culture test with the Xpert meticillin-resistant Staphylococcus aureus (MRSA) assay for screening inpatients at high risk of MRSA.
    Li J; Ulvin K; Biboh H; Kristiansen IS
    J Hosp Infect; 2012 Dec; 82(4):227-33. PubMed ID: 23098683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national one week prevalence audit of universal meticillin-resistant Staphylococcus aureus (MRSA) admission screening 2012.
    Fuller C; Robotham J; Savage J; Hopkins S; Deeny SR; Stone S; Cookson B
    PLoS One; 2013; 8(9):e74219. PubMed ID: 24069282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study.
    Lawes T; Lopez-Lozano JM; Nebot CA; Macartney G; Subbarao-Sharma R; Dare CR; Wares KD; Gould IM
    Lancet Infect Dis; 2015 Dec; 15(12):1438-49. PubMed ID: 26411518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?
    Papia G; Louie M; Tralla A; Johnson C; Collins V; Simor AE
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):473-7. PubMed ID: 10432159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T; Oh PI; Simor AE
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective.
    von Dach E; Morel CM; Murthy A; Pagani L; Macedo-Vinas M; Olearo F; Harbarth S
    Clin Microbiol Infect; 2017 Sep; 23(9):659-666. PubMed ID: 28232163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Yield of Methicillin-Resistant Staphylococcus aureus Screening in Hemodialysis Patients: 10 Years' Experience.
    Gebreselassie HM; Kaspar T; Droz S; Marschall J
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1046-9. PubMed ID: 26008616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of screening risk and nonrisk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital.
    Creamer E; Galvin S; Dolan A; Sherlock O; Dimitrov BD; Fitzgerald-Hughes D; Thomas T; Walsh J; Moore J; Smyth EG; Shore AC; Sullivan D; Kinnevey P; O'Lorcain P; Cunney R; Coleman DC; Humphreys H
    Am J Infect Control; 2012 Jun; 40(5):411-5. PubMed ID: 21962934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA).
    Roth VR; Longpre T; Coyle D; Suh KN; Taljaard M; Muldoon KA; Ramotar K; Forster A
    PLoS One; 2016; 11(7):e0159667. PubMed ID: 27462905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.